Influenza Pandemics of the 20th Century, Emerging Infectious Diseases, vol.12, issue.1, pp.9-14, 2006. ,
DOI : 10.3201/eid1201.051254
Quantifying influenza vaccine efficacy and antigenic distance, Vaccine, vol.24, issue.18, pp.3881-3889, 2006. ,
DOI : 10.1016/j.vaccine.2006.01.010
Assessing Antigenic Drift of Seasonal Influenza A(H3N2) and A(H1N1)pdm09 Viruses, PLOS ONE, vol.31, issue.01, 2015. ,
DOI : 10.1371/journal.pone.0139958.s006
Genetic and antigenic characterization of hemagglutinin of influenza A/H3N2 virus from the 2015 season in Thailand, Virus Genes, vol.141, issue.Suppl. 3, pp.711-716, 2016. ,
DOI : 10.1007/BF01718836
Oseltamivir-resistant Influenza A and B Viruses Pre- and Postantiviral Therapy in Children and Young Adults With Cancer, The Pediatric Infectious Disease Journal, vol.30, issue.4, pp.284-292, 2011. ,
DOI : 10.1097/INF.0b013e3181ff863b
Molecular surveillance of antiviral drug resistance of influenza A/H3N2 virus in Singapore):e0117822. https, PLoS One, vol.10, issue.1, p.25635767, 2009. ,
Antiviral drug profile of human influenza A & B viruses circulating in India The Indian journal of medical research, pp.2004-2011244, 2014. ,
Full Genome Characterization of Human Influenza A/H3N2 Isolates from Asian Countries Reveals a Rare Amantadine Resistance-Conferring Mutation and Novel PB1-F2 Polymorphisms, Frontiers in Microbiology, vol.15, pp.262-27014195, 2016. ,
DOI : 10.3851/IMP1538
The I222V Neuraminidase Mutation Has a Compensatory Role in Replication of an Oseltamivir-Resistant Influenza Virus A/H3N2 E119V Mutant, Journal of Clinical Microbiology, vol.49, issue.2, pp.715-722, 2011. ,
DOI : 10.1128/JCM.01732-10
Detection of E119V and E119I Mutations in Influenza A (H3N2) Viruses Isolated from an Immunocompromised Patient: Challenges in Diagnosis of Oseltamivir Resistance, Antimicrobial Agents and Chemotherapy, vol.54, issue.5, pp.1834-1875, 2010. ,
DOI : 10.1128/AAC.01608-09
Characterization of Multidrug-Resistant Influenza A/H3N2 Viruses Shed during 1 Year by an Immunocompromised Child, Clinical Infectious Diseases, vol.43, issue.12, pp.1555-61, 2006. ,
DOI : 10.1086/508777
Impact of neuraminidase mutations conferring influenza resistance to neuraminidase inhibitors in the N1 and N2 genetic backgrounds, Antiviral therapy, vol.11, issue.8, pp.971-977, 2006. ,
A Novel Neuraminidase Deletion Mutation Conferring Resistance to Oseltamivir in Clinical Influenza A/H3N2 Virus, The Journal of Infectious Diseases, vol.199, issue.2, pp.180-183, 2009. ,
DOI : 10.1086/595736
Epidemiological and Virological Characteristics of Influenza Viruses Circulating in Cambodia from, PLoS One, vol.9, issue.10, 2009. ,
Identification of Hemagglutinin Residues Responsible for H3N2 Antigenic Drift during the 2014?2015 Influenza Season, Cell Reports, vol.12, issue.1, pp.1-6, 2015. ,
Effect of mass paediatric influenza vaccination on existing influenza vaccination programmes in England and Wales: a modelling and cost-effectiveness analysis, The Lancet Public Health, vol.2, issue.2, pp.74-81, 2017. ,
DOI : 10.1016/S2468-2667(16)30044-5
Antiviral resistance of influenza A (H3N2) strains isolated in northern Greece between Euro surveillance: bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2004. ,